A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.

Suppr

超能文献

作者信息

Fisher Maxwell E, Rossini Michele, Simmons Edith, Harris Raymond C, Moeckel Gilbert, Zent Roy

机构信息

Division of Nephrology, Vanderbilt Medical Center, Nashville, TN 37232, USA

出版信息

Am J Kidney Dis. 2004 Sep;44(3):567-73.

PMID:15332232

Abstract

摘要

相似文献

A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.

Am J Kidney Dis. 2004 Sep;44(3):567-73.

[Nephrotic syndrome with acute renal failure due to focal segmental glomerulosclerosis in a patient treated with alpha-interferon for chronic hepatitis C].

Gastroenterol Clin Biol. 2000 Apr;24(4):465.

Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy.

Am J Kidney Dis. 1996 Dec;28(6):888-92. doi: 10.1016/s0272-6386(96)90389-3.

Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.

Am J Clin Oncol. 2003 Jun;26(3):262-4. doi: 10.1097/01.COC.0000020649.11411.2B.

[Chronic hepatitis C in a 12-year-old girl coinfected with HGV].

Pol Merkur Lekarski. 1999 Jul;7(37):21-2.

Focal segmental glomerulosclerosis and hepatitis C virus: a case report.

Panminerva Med. 2001 Mar;43(1):49-52.

Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.

J Drugs Dermatol. 2009 Sep;8(9):870-2.

[Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].

Recenti Prog Med. 2004 Nov;95(11):525-8.

Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac.

Wien Klin Wochenschr. 1999 Jul 9;111(13):523-4.

Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.

J Assoc Physicians India. 2004 Jun;52:514.

引用本文的文献

Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases.

Front Bioeng Biotechnol. 2021 Aug 10;9:704077. doi: 10.3389/fbioe.2021.704077. eCollection 2021.

Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.

Sci Rep. 2019 Jul 26;9(1):10867. doi: 10.1038/s41598-019-47074-y.

Anti-hepatitis C virus drugs and kidney.

World J Hepatol. 2016 Nov 18;8(32):1343-1353. doi: 10.4254/wjh.v8.i32.1343.

Side effects of cytokines approved for therapy.

Drug Saf. 2014 Nov;37(11):921-43. doi: 10.1007/s40264-014-0226-z.

De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).

Dig Dis Sci. 2014 Mar;59(3):691-5. doi: 10.1007/s10620-013-2959-4. Epub 2013 Dec 8.

Collapsing glomerulopathy as a complication of interferon therapy for hepatitis C infection.

Int Urol Nephrol. 2010 Mar;42(1):219-22. doi: 10.1007/s11255-009-9594-1. Epub 2009 Jun 4.

HCV infection complicated with nephrotic syndrome, immune complex crescentic glomerulonephritis and acute renal failure: a case report.

Kaohsiung J Med Sci. 2005 Oct;21(10):470-4. doi: 10.1016/S1607-551X(09)70153-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验